What happened
Genesystem's controlling stake is set to change hands from an individual to an investment partnership, in a deal worth US$4.11M.
A change of the controlling shareholder can reshape a company's strategy, capital allocation, and board.
| From | an individual |
|---|---|
| To | an investment partnership |
| Deal value | US$4.11M |
| Filed | 2026-02-10, Agreement on change of control signed |
| Source | DART rcept 20260210900100 → open original filing |
Source: DART. Information only, not investment advice.

